about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
20.10
0.61
(3.13%)
291.3K
XNAS Volume
XNAS 06 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..